ATE92930T1 - Saponinkomplexe mit phospholipiden und sie enthaltende pharmazeutische und kosmetische zusammensetzungen. - Google Patents

Saponinkomplexe mit phospholipiden und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.

Info

Publication number
ATE92930T1
ATE92930T1 AT88102321T AT88102321T ATE92930T1 AT E92930 T1 ATE92930 T1 AT E92930T1 AT 88102321 T AT88102321 T AT 88102321T AT 88102321 T AT88102321 T AT 88102321T AT E92930 T1 ATE92930 T1 AT E92930T1
Authority
AT
Austria
Prior art keywords
pharmaceutical
cosmetic compositions
phospholipids
compositions containing
complexes
Prior art date
Application number
AT88102321T
Other languages
English (en)
Inventor
Ezio Bombardelli
Gian Franco Patri
Roberto Pozzi
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of ATE92930T1 publication Critical patent/ATE92930T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/256—Polyterpene radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
    • A61K47/544—Phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C07F9/106—Adducts, complexes, salts of phosphatides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cosmetics (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
AT88102321T 1987-02-26 1988-02-18 Saponinkomplexe mit phospholipiden und sie enthaltende pharmazeutische und kosmetische zusammensetzungen. ATE92930T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT19496/87A IT1203515B (it) 1987-02-26 1987-02-26 Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono
EP88102321A EP0283713B1 (de) 1987-02-26 1988-02-18 Saponinkomplexe mit Phospholipiden und sie enthaltende pharmazeutische und kosmetische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE92930T1 true ATE92930T1 (de) 1993-08-15

Family

ID=11158516

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88102321T ATE92930T1 (de) 1987-02-26 1988-02-18 Saponinkomplexe mit phospholipiden und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.

Country Status (8)

Country Link
US (2) US5118671A (de)
EP (1) EP0283713B1 (de)
JP (1) JP2768465B2 (de)
AT (1) ATE92930T1 (de)
DE (1) DE3883035T2 (de)
ES (1) ES2058151T3 (de)
HK (1) HK160895A (de)
IT (1) IT1203515B (de)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166139A (en) * 1987-02-26 1992-11-24 Indena, S.P.A. Complexes of saponins and their aglycons with phospholipids and pharmaceutical and cosmetic compositions containing them
IT1203515B (it) * 1987-02-26 1989-02-15 Indena Spa Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono
US5583112A (en) * 1987-05-29 1996-12-10 Cambridge Biotech Corporation Saponin-antigen conjugates and the use thereof
DE4006563C2 (de) * 1988-09-02 1994-06-30 Reutter Werner Verwendung von Phosphatesterderivaten als Wirkstoffe in Kosmetika und sie enthaltende kosmetische Präparate
ATE119384T1 (de) * 1988-12-22 1995-03-15 Kanebo Ltd Kosmetisches präparat.
US5567419A (en) * 1988-12-22 1996-10-22 Kanebo Ltd. Stabilized cosmetic compositions containing monoacyl phosphatide and a saponin
KR910008736B1 (ko) * 1989-06-13 1991-10-19 태평양화학주식회사 4급암모니움-치환된 사포닌 에테르 유도체 및 그 제조방법
IT1238684B (it) * 1990-02-09 1993-09-01 Indena Spa Derivati del bilobalide,loro usi e formulazioni che li contegono
EP0464297B1 (de) * 1990-07-05 1995-05-17 INDENA S.p.A. Neolignanderivatkomplexen mit Phospolipiden, deren Verwendung und sie enthaltende pharmazeutische und kosmetische Zusammensetzungen
ATE148713T1 (de) * 1990-07-24 1997-02-15 Seikagaku Kogyo Co Ltd Glykosaminoglykan gemischt mit phospholipid oder lipid, seine herstellung und krebszellenmetastaseninhibitor
US5733892A (en) * 1990-07-24 1998-03-31 Seikagaku Corporation Metastasis inhibitor composition comprising a phospholipid-linked glycosaminoglycan and method for inhibiting metastasis employing the same
EP0509656B1 (de) * 1991-03-28 1996-09-18 Rooperol (Na) Nv Zusammensetzungen von Phytosterolen mit Phytosterolinen als Immunmodulatoren
US5356880A (en) * 1991-05-30 1994-10-18 Sanwa Kagaku Kenkyusho Co., Ltd. Glycyrrhetinic acid derivatives
IT1251497B (it) * 1991-09-18 1995-05-15 Mivett Nuovi Lab Di Pavani& C Uso di 1,2 dipalmitoil-l-alfa-fosfatidil-n,n-dimetiletanolammina, in composizioni dermatologiche
JPH06247842A (ja) * 1993-02-23 1994-09-06 Green Cross Corp:The リポソーム組成物の製造方法
US5527890A (en) * 1993-04-16 1996-06-18 Glycomed Incorporated Derivatives of triterpenoid acids and uses thereof
FR2714382B1 (fr) * 1993-12-27 1996-02-02 Roussel Uclaf Phospholipides vecteur de molécule active, leur préparation et leur utilisation dans des compositions cosmétiques ou dermatologiques.
US5688772A (en) * 1994-08-01 1997-11-18 University Of Saskatchewan Quinoa saponin compositions and methods of use
US5597807A (en) * 1994-08-01 1997-01-28 University Of Saskatchewan Quinoa saponin compositions and methods of use
US5523087A (en) * 1995-02-15 1996-06-04 Bio-Virus Research Incorporated Pharmaceutical compositions for the treatment of diabetic male sexual dysfunction
IT1284971B1 (it) * 1996-10-17 1998-05-28 Indena Spa Formulazioni farmaceutiche e cosmetiche ad attivita' antiacne
US6267996B1 (en) 1996-10-17 2001-07-31 Indena S.P.A Pharmaceutical and cosmetic formulations with antimicrobial activity
FR2755012A1 (fr) * 1996-10-31 1998-04-30 Slow Age Creations Composition topique destinee a augmenter la souplesse et l'elasticite du buste pendant la phase premenstruelle
FR2757391B1 (fr) * 1996-12-20 1999-03-12 Dior Christian Parfums Utilisation d'un extrait de la plante terminalia, dans les domaines cosmetique et pharmaceutique, notamment dermatologique
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
FR2767057B1 (fr) * 1997-08-08 1999-10-29 Lvmh Rech Utilisation du ginsenoside rb1 comme agent destine a stimuler la synthese de l'elastine
US5985936A (en) * 1997-12-18 1999-11-16 Forbes Medi-Tech, Inc. Method of preventing and delaying onset of Alzheimer's disease and composition therefor
US8093293B2 (en) * 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
CA2246791A1 (en) * 1998-09-01 2000-03-01 Alison Buchan Treatment of endothelium with somatostatin analogues
ES2141687B1 (es) * 1998-09-07 2000-11-01 Provital S A Complejo vegetal antipolucion, procedimiento para su obtencion y uso del mismo en la preparacion de composiciones farmaceuticas y/o cosmeticas.
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
WO2001017523A1 (en) * 1999-09-10 2001-03-15 Applied Genetics Incorporated Dermatics Compositions and methods for modification of skin lipid content
US6982284B1 (en) 1999-09-10 2006-01-03 Applied Genetics Incorporated Dermatics Compositions and methods for modification of skin lipid content
US7309688B2 (en) * 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
GB0004686D0 (en) * 2000-02-28 2000-04-19 Aventis Pharma Ltd Chemical compounds
US6191121B1 (en) * 2000-04-06 2001-02-20 Nicholas V. Perricone Treatment of skin damage using polyenylphosphatidylcholine
US6979459B1 (en) 2000-04-06 2005-12-27 Perricone Nicholas V Treatment of skin damage using polyenylphosphatidycholine
US6932963B2 (en) 2000-06-23 2005-08-23 Nicholas V. Perricone Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines
MY138883A (en) * 2000-08-29 2009-08-28 Government Of Malaysia As Represented By The Ministry Of Science Tehnology And Innovation Malaysia Use of asiatic acid for treatment of cencer
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
ITMI20010429A1 (it) 2001-03-02 2002-09-02 Indena Spa Composizioni farmaceutiche e cosmetiche per la protezione della pelledai danni indotti dalle radiazioni solari
DE10121092A1 (de) * 2001-04-26 2002-10-31 Beiersdorf Ag Kosmetische oder dermatologische Formulierungen mit einem Gehalt an Sericosid und/oder Pflanzenextrakten, dasselbe enthaltend
DE10121090A1 (de) * 2001-04-26 2002-10-31 Beiersdorf Ag Wirkstoffkombinationen aus Tetrahydrocurcuminoiden und Sericosid und/oder Pflanzenextrakten
ITMI20011022A1 (it) * 2001-05-17 2002-11-17 Indena Spa Composizioni farmaceutiche e cosmetiche contro l'invecchiamento cutaneo
ITMI20011182A1 (it) * 2001-06-05 2002-12-05 Indena Spa Composizioni farmaceutiche e/o cosmetiche per il trattamento di adiposita' localizzate e della cellulite
US20030003131A1 (en) * 2001-06-22 2003-01-02 Matthew Dyer Method for manufacture of free-flowing powder containing water-dispersible sterols
US6753414B2 (en) * 2001-08-07 2004-06-22 University Of Iowa Research Foundation, Inc. Process for preparing saponin compounds
DE10146500A1 (de) * 2001-09-21 2003-04-17 Beiersdorf Ag Kosmetische und/oder dermatologische Wirkstoffkombination
JP4549625B2 (ja) 2002-01-05 2010-09-22 株式會社アモーレパシフィック 人参サポニン代謝産物を有効成分とする微細乳化粒子及びその製造方法、並びにこれを含有する皮膚老化防止用の化粧料組成物
US20030224075A1 (en) * 2002-02-21 2003-12-04 Jue-Chen Liu Soy composition for balancing combination skin
US6861410B1 (en) * 2002-03-21 2005-03-01 Chiron Corporation Immunological adjuvant compositions
WO2003086108A1 (en) * 2002-04-10 2003-10-23 Archer-Daniels-Midland Company Hydrothermically processed compositions containing phytosterols
US20060093661A1 (en) 2002-05-07 2006-05-04 Kapac, Llc Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
US20030212046A1 (en) * 2002-05-07 2003-11-13 Kapac, Llc Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
ITMI20031427A1 (it) * 2003-07-11 2005-01-12 Indena Spa Combinazioni di agenti vasoattivi, loro uso in campo farmaceutico e cosmetico e formulazioni che li contengono
ITMI20031789A1 (it) * 2003-09-19 2005-03-20 Indena Spa Composizioni farmaceutiche e cosmetiche per il trattamento
AU2004277906A1 (en) * 2003-09-22 2005-04-14 Degussa Health & Nutrition Americas, Inc. Incorporation of phytosterols into flavorings
EP1618885A1 (de) * 2004-07-10 2006-01-25 Cognis IP Management GmbH Kosmetische und/oder pharmazeutische Zubereitung enthaltend Fettsäurenfettsäauren und Extrakten von Castanea Sativa
EP1811839A4 (de) * 2004-11-18 2008-08-06 Univ Rochester Verfahren und zusammensetzungen in verbindung mit esculentosid a
CN1311823C (zh) * 2004-11-19 2007-04-25 中国药科大学 靛玉红磷脂复合物及其制备方法
CA2657674A1 (en) * 2006-02-17 2007-08-23 Wuhan University The application of glycyrrhizic acid and its breakdown product glycyrrhetinic acid for the manufacture of a medicament for the treatment of inflammatory bowel disease
EP1837030A1 (de) 2006-03-09 2007-09-26 INDENA S.p.A. Curcumin-phospholipid-Komplexe mit verbesserter Bioverfügbarkeit
EP1844785A1 (de) * 2006-04-13 2007-10-17 Indena S.P.A. Phospholipidkomplexe der Extrakte aus Oliven und Olivenblättern mit verbesserter Bioverfügbarkeit
US20080124387A1 (en) * 2006-11-27 2008-05-29 Kapac, Llc Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrients
CN101530389B (zh) * 2008-03-11 2012-02-15 沈阳市万嘉生物技术研究所 人参皂苷Rg3磷脂复合物及其制备方法
FR2933608B1 (fr) * 2008-07-11 2014-01-10 Lvmh Rech Nouvelle utilisation d'un extrait de grande mauve agent hydratant, et composition cosmetique le contenant.
PL214648B1 (pl) 2009-02-09 2013-08-30 Univ W Bialymstoku Zastosowanie analogów saponiny OSW-1 o uproszczonej budowie wykazujacych dzialanie cytotoksyczne
JP5476013B2 (ja) * 2009-03-27 2014-04-23 株式会社ファンケル 皮膚外用剤
WO2011144439A1 (en) 2010-05-18 2011-11-24 Indena S.P.A. Compositions for the treatment of gynaecological disorders
US8039025B1 (en) 2010-10-15 2011-10-18 Life Plus, LLC Methods and dosage forms for the treatment of human cancers
CN102250187B (zh) * 2011-04-25 2013-03-27 北京中海康医药科技发展有限公司 一种甘草次酸衍生物及其制备方法
CN103110589B (zh) * 2013-01-24 2014-12-10 沈阳药科大学 拟人参皂苷f11磷脂复合物及制备方法和用途
JP2013199501A (ja) * 2013-07-10 2013-10-03 Kao Corp 保湿剤
US20150110908A1 (en) 2013-10-21 2015-04-23 Ocusoft, Inc. Compositions, Kits, and Methods for Ameliorating Oculoplastic Post-Procedural Effects
CN105662974A (zh) * 2016-03-10 2016-06-15 江苏隆力奇生物科技股份有限公司 一种预防皮肤光老化功能制剂及其应用
EP3703724A1 (de) 2017-11-02 2020-09-09 NatureCeuticals Sdn. Bhd. Extrakt aus orthosiphon stamineus, formulierungen und verwendungen davon
CN111285916B (zh) * 2020-02-14 2021-07-02 浏阳朗林生物科技有限公司 一种积雪草总苷含量高的积雪草提取物的制备方法
CN116159145A (zh) * 2023-01-31 2023-05-26 四川大学 含七叶皂苷和/或其盐化合物的转染复合物在促转染的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA462710A (en) * 1950-01-24 P. Langlois David Preparation of phytosterol glucosides
GB887012A (en) * 1959-07-24 1962-01-10 Biorex Laboratories Ltd Process for the preparation of 18ª--glycyrrhetinic acid
DE1217547B (de) * 1962-10-16 1966-05-26 Chem Fab Tempelhof Preuss & Te Verfahren zur Herstellung von Saponin-Komplexen mit lipoidartigem Loeslichkeits-charakter
GB1503388A (en) * 1975-07-01 1978-03-08 Inverni Della Beffa Spa Pharmaceutically active complexes and pharmaceutical compositions containing them
JPS5942393A (ja) * 1982-08-31 1984-03-08 Nippon Shinyaku Co Ltd リン脂質の分離法
JPS59187792A (ja) * 1983-04-11 1984-10-24 Meito Sangyo Kk 酵素法リン脂質糖類誘導体の製法
EP0142193A1 (de) * 1983-10-22 1985-05-22 Akzo N.V. Herstellung von Immunogenen bestehend aus an Glykosid enthaltenden Trägern gebundenen Antigenen und/oder antigenen Determinanten
JPS62238299A (ja) * 1986-04-09 1987-10-19 Nisshin Oil Mills Ltd:The ステリルグルコシドの濃縮・分離法
IT1203515B (it) * 1987-02-26 1989-02-15 Indena Spa Complessi di saponine con fosfolipidi e composizioni farmaceutiche e cosmetiche che li contengono

Also Published As

Publication number Publication date
US5118671A (en) 1992-06-02
DE3883035D1 (de) 1993-09-16
JPS63277691A (ja) 1988-11-15
HK160895A (en) 1995-10-20
JP2768465B2 (ja) 1998-06-25
EP0283713A2 (de) 1988-09-28
IT1203515B (it) 1989-02-15
EP0283713B1 (de) 1993-08-11
EP0283713A3 (en) 1990-03-07
IT8719496A0 (it) 1987-02-26
DE3883035T2 (de) 1993-12-02
ES2058151T3 (es) 1994-11-01
US5147859A (en) 1992-09-15

Similar Documents

Publication Publication Date Title
ATE92930T1 (de) Saponinkomplexe mit phospholipiden und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
HK160995A (en) Complex compounds of bioflavonoids with phospholipids their preparation and use and pharmaceutical and cosmetic compositions containing them
DE58905028D1 (de) Pharmazeutische kombinationspraeparate und deren verwendung als antineoplastische arzneimittel.
ATE81588T1 (de) Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen.
NO170126C (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater i form av suspensjoner som inneholder sucralfat
ATE124253T1 (de) Verwendung von pharmazeutischen und kosmetischen präparaten mit mischmicellen.
GB2305107B (en) Biological materials preserved by antioxidant synthetic catalytic free radical scavengers
DE3882383D1 (de) Phospholipidische komplexe aus vitis vinifera-extrakten, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
ZA90963B (en) Diphenylheteroalkyl derivatives,the preparation thereof and drugs and cosmetics prepared therefrom
ATE122565T1 (de) Neolignanderivatkomplexen mit phospolipiden, deren verwendung und sie enthaltende pharmazeutische und kosmetische zusammensetzungen.
ATE99945T1 (de) Verwendung von 5'-deoxy-5'-methylthioadenosin s- adenosylmethionin und dessen salzen zur herstellung von seborrhea vermindernden arzneimitteln.
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
IL58103A (en) Sila-substituted 1,4-dihydropyridine derivatives,their production and pharmaceutical compositions containing them
FI101597B1 (fi) Menetelmä kylmäkuivatun koostumuksen valmistamiseksi käytettäväksi potilaan valodynaamisessa hoidossa tai diagnosoinnissa
ATE77048T1 (de) Bioemulgatoren enthaltende kosmetische und pharmazeutische zusammensetzungen.
IE852755L (en) Solid drug formulation
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
AU6278680A (en) Carbamates and pharmaceutical formulations containing them
DE3484355D1 (de) Gefaerbte wasserfreie mittel fuer kosmetische, medizinische und aehnliche zwecke, sowie deren herstellung.
ATE2746T1 (de) Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
EP0190860A3 (de) 6-Chloro-3-methyl-1H-2,3,4,5-tetrahydro-3-benzazepin-N-oxyd und dieses enthaltende Arzneimittel
DE3879709D1 (de) Platin-arzneimittel.
DE69004051D1 (de) Verwendung eines Polypeptides mit Gammainterferon-Aktivität zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von primitivem Pleura-Krebs.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties